news
US drugmakers allegedly collude on generic price hikes
A coalition of 43 attorneys general allege generic drug manufacturers colluded, overcharging US states and consumers billions.
List view / Grid view
Teva Pharmaceuticals USA
news
FDA approves first generic Strattera for the treatment of ADHD
31 May 2017 | By Niamh Marriott, Junior Editor
The US Food and Drug Administration has approved the first generic versions of Strattera (atomoxetine) to treat (ADHD) in pediatric and adult patients...
news
Teva Pharmaceuticals and Volunteers in Medicine partner to expand access to healthcare in the U.S.
10 March 2014 | By Teva
Teva Pharmaceuticals USA and Volunteers in Medicine announced their 2014 National Partnership to make healthcare services more readily available to the uninsured...
news
Teva and Alexza announce Teva’s license to market ADASUVE® in the U.S.
8 May 2013 | By TEVA
Teva and Alexza have entered into an exclusive U.S. license and supply agreement...
news
GlaxoSmithKline confirms US District Court ruling in Pronova BioPharma’s favour on Lovaza™ patents
29 May 2012 | By GlaxoSmithKline
GSK which has the marketing rights for Lovaza in the US and Puerto Rico...
news
Pfizer wins Viagra patent trial
15 August 2011 | By Pfizer
Pfizer Inc. has prevailed in its patent infringement action against Teva Pharmaceuticals USA, Inc. in the United States District Court for the Eastern District of VA...
